When was Diasend founded?

Diasend was founded in 2005 and raised its 1st funding round 12 years after it was founded.

Where is Diasend located?

Diasend is headquartered in Chicago, United States.

How many employees does Diasend have?

As of Dec 31, 2016, Diasend has 10 employees, reflecting a 12% year-over-year growth in headcount.

Is Diasend a funded company?

Diasend is a funded company, having raised a total of $***** in its 1st and only funding round, a Grant (prize money) round on Jan 01, 2017.

When was the latest funding round of Diasend?

Diasend's latest funding was a $***** Grant (prize money) round on Jan 01, 2017, with participation from 1 investor. Its primary sector is Disease Self Management. In United States, the Disease Self Management sector has seen $812M in funding in 2026 to date.

Where does Diasend rank among its competitors?

Diasend ranks 65th amongst 932 active competitors, of which 157 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Brook, which secured $28M in Oct, 2025.

Who are the top competitors of Diasend?

Diasend's top competitors include BeatO, Zyla and Vytalize Health. Among them, Brook secured the most recent funding round in October, 2025.

Diasend - 2026 Company Profile, Team, Funding & Competitors

Company Details

Diabetes data management platform transitioning to Glooko, offering device syncing and tracking. This platform enables users to synchronize and review data from their diabetes devices, track blood glucose levels, monitor food intake and exercise, and stay connected with their care teams. It facilitates comprehensive diabetes management through data integration and communication tools. The service provides a solution for individuals to monitor their health metrics and share information with healthcare providers. It is a software solution designed to improve diabetes care through data-driven insights and enhanced connectivity. The platform offers features such as data syncing, health tracking, and care team communication, supporting better health outcomes for users. It is a B2C and B2B platform, offering a SaaS model for diabetes management.

Website: diasend.com
Social

Key Metrics

Founded Year

2005

Location

Chicago, United States

Stage

Acquired

Latest Funding Round

Grant (prize money), Jan 01, 2017, $*****

Investors

Sahlgrenska Science Park & 3 more

Ranked

65^th among 932 active competitors

Employee Count

10 as on Dec 31, 2016

Similar Companies

BeatO & 947 more

Exit Details

Acquired by Glooko (Sep 12, 2016)

View Diasend's full profile

Diasend is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Diasend, Inc. CIN: 611592314 , United Kingdom, Active		-	10 (As on Dec 31, 2016)

Diasend got acquired by Glooko on Sep 12, 2016.

Click here to take a look at Diasend's acquisition in detail

Diasend has raised funding over 1 round. Its latest funding round was a Grant (prize money) round on Jan 01, 2017 for $*****. 1 investor participated in its latest round. Diasend has 4 institutional investors.

Here is the list of recent funding rounds of Diasend:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2017	7709007	Grant (prize money)	5872974	3253651	5626969	6460821

Access funding benchmarks and valuations. Sign up today!

View details of Diasend's funding rounds and investors

Diasend's employee count trend

Diasend has 10 employees as of Dec 16. The total employee count is 11.0% more than what it was in Dec 15. Here is Diasend's employee count trend over the years:

Uncover Diasend's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Diasend include BeatO, Zyla and Vytalize Health. Here is the list of Top 10 competitors of Diasend, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	BeatO 2015, Delhi (India), Series B	Provider of a smartphone-enabled glucometer and diabetes management app	$50.8M	Orios Venture Partners, W Health Ventures ... & 62 others	68/100
2nd	Zyla 2017, Gurugram (India), Series A	AI-based healthcare management platform offering various solutions	$6.27M	Secocha Ventures, Kae Capital & 49 others	68/100
3rd	Vytalize Health 2014, New York City (United States), Series B	Mobile app to book on demand in home healthcare services	$170M	Enhanced Healthcare Partners, Hudson River Capital Partners ... & 11 others	67/100
4th	Wellframe 2011, Boston (United States), Acquired	Mobile and AI-based platform offering support to providers for better patient engagement	$45.1M	F-Prime Capital, DFJ & 14 others	63/100
5th	Glooko 2010, Palo Alto (United States), Series F	Glucose meter and mobile app for diabetes management	$201M	Social Capital, Georgian & 22 others	63/100
6th	ChartSpan 2012, Greenville (United States), Series A	Mobile app for Patient health records	$37.2M	Cypress Growth Capital, BIP Capital & 9 others	63/100
7th	Brook 2015, Series A	Provider of remote patient care blending clinical teams with artificial intelligence	$32M	UMass, Morningside & 1 others	62/100
8th	Strive Health 2008, Denver (United States), Series D	Provider of value-based kidney care solutions. It offers comprehensive care programs for patients with chronic kidney disease, encompassing various stages of the disease, including dialysis and transplantation. The company partners with healthcare systems, payors, and nephrologists to deliver integrated care, utilizing a technology platform for predictive analytics and personalized care plans. Services include population health management and multi-specialty care teams. The goal is to improve patient outcomes and reduce the overall cost of care.	$606M	New Enterprise Associates, CapitalG & 10 others	61/100
9th	PatientPing 2013, Boston (United States), Acquired	Cloud based care coordination and management tool for providers	$103M	F-Prime Capital, Google Ventures & 8 others	60/100
10th	Memora Health 2015, Boston (United States), Acquired	Mobile platform for chronic disease management	$80.6M	Transformation Capital, Andreessen Horowitz ... & 22 others	59/100
65th	Diasend 2005, Chicago (United States), Acquired	Diabetes data management platform transitioning to Glooko, offering device syncing and tracking	-	Sahlgrenska Science Park, Almi Invest & 2 others	42/100